- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
There's not much reason to be bullish on these stocks.
Regeneron has faced a lower stock price and patent wrangling. But the stock could be ready to rise again.
There could be a major windfall for Fortune 500 companies.